Results per Page:
Infectious disease experts propose trials network dedicated to immunocompromised patients
ImmunOptimize workshop convened stakeholders across disciplines to brainstorm infectious disease clinical trials network designed to serve people with weakened immune systems
Dr. Mazyar Shadman, new medical director of the Bezos Family Immunotherapy Clinic, says immunotherapy services are expanding to meet demand
Increasing timely access to immunotherapy is a main goal
Safety and feasibility approved for new therapy to treat relapsed hematologic malignancies
From the Bleakley Lab, Translational Science & Therapeutics Division
Boosting the effectiveness of CAR T-cell therapies against AML
Dr. Erik Kimble wins award from the American Society of Gene & Cell Therapy
Stress, caused by RNA:DNA hybrids, holds the key to treating select leukemias
From the Stanley Lee lab, Translational Science and Therapeutics Division
Effective immunotherapy for relapsed or treatment-resistant leukemia
From Dr. Jordan Gauthier and colleagues, Clinical Research Division
Dr. Ajay Gopal named Stephen H. Petersdorf Endowed Chair in Cancer Care at UW Medicine
Chair honors his dedication to improving patient care through research
Leader in apheresis and cellular therapy, Dr. Michael Linenberger, retires
As professor emeritus, this respected mentor will continue to contribute to the UW fellowship program
A giant in BMT survivorship
Dr. Mary Flowers steps down from leading Fred Hutch BMT Long-Term Follow-Up program
Depleting exhausted T cells enables memory T cells to be activated and fight blood cancer
From the Hill Lab, Clinical Research Division
New approach could make bone marrow transplantation safer, stronger
Tests prevented relapse, limited GVHD in laboratory models of leukemia, multiple myeloma
Epigenetic heterogeneity helps cancer cells change their minds
From the Henikoff Lab, Basic Sciences Division and the Meshinchi Lab, Clinical Research Division